[Intermittent androgen suppression for prostate cancer].
Akakura
K
K
Department of Urology, Chiba University School of Medicine.
Ito
H
H
Sato
N
N
D000726:Androgen Antagonists / Q000008:administration & dosage*; D000728:Androgens / Q000008:administration & dosage*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000726:Androgen Antagonists; D000728:Androgens